[1]
Ramachandaram, A., Sarvanandan, T. , Hee, N.K.Y. , Lim, Q.H. , Paramasivam, S., Lim, L.L., Chan, S.P., Vethakkan, S., Lim, S.K. and Ratnasingam , J. 2023. REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE. Journal of the ASEAN Federation of Endocrine Societies. 38, S3 (Nov. 2023), 52.